Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine

Ted M. Burns, Gordon A. Smith, Jeffrey A. Allen, Anthony A. Amato, W. David Arnold, Richard Barohn, Michael Benatar, Shawn J. Bird, Mark Bromberg, Nizar Chahin, Emma Ciafaloni, Jeffrey A. Cohen, Andrea Corse, Brian A. Crum, William S. David, Elliot Dimberg, Eduardo A. De Sousa, Peter D. Donofrio, P. James B. Dyck, Andrew G. EngelErik R. Ensrud, Mark Ferrante, Miriam Freimer, Karissa L. Gable, Summer Gibson, James M. Gilchrist, Jonathan M. Goldstein, Clifton L. Gooch, Brent P. Goodman, Dmitri Gorelov, Sidney M. Gospe, Namita A. Goyal, Amanda C. Guidon, Jeffrey T. Guptill, Laurie Gutmann, Ludwig Gutmann, Kelly Gwathmey, Yadollah Harati, C. Michel Harper, Michael K. Hehir, Lisa D. Hobson-Webb, James F. Howard, Carlayne E. Jackson, Nicholas Johnson, Sarah M. Jones, Vern C. Juel, Henry J. Kaminski, Chafic Karam, Kathleen D. Kennelly, Sami Khella, Julie Khoury, John C. Kincaid, John T. Kissel, Noah Kolb, David Lacomis, Shafeeq Ladha, Daniel Larriviere, Richard A. Lewis, Yuebing Li, William J. Litchy, Eric Logigian, Jau Shin Lou, Daniel J.L. Macgowen, Ricardo Maselli, Janice M. Massey, Michelle L. Mauermann, Katherine D. Mathews, Matthew N. Meriggioli, Robert G. Miller, Joon Shik Moon, Tahseen Mozaffar, Sharon P. Nations, Richard J. Nowak, Lyle W. Ostrow, Robert M. Pascuzzi, Amanda Peltier, Katherine Ruzhansky, David P. Richman, Mark A. Ross, Devon I. Rubin, James A. Russell, George M. Sachs, Mohammad Kian Salajegheh, David S. Saperstein, Stephen Scelsa, Duygu Selcen, Aziz Shaibani, Perry B. Shieh, Nicholas J. Silvestri, J. Rob Singleton, Benn E. Smith, Yuen T. So, Guillermo Solorzano, Eric J. Sorenson, Jayashri Srinivasen, Jinny Tavee, Rabi Tawil, Pariwat Thaisetthawatkul, Charles Thornton, Jaya Trivedi, Steven Vernino, Annabel K. Wang, Tyler A. Webb, Michael D. Weiss, Anthony J. Windebank, Gil I. Wolfe

Research output: Contribution to journalEditorialpeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine'. Together they form a unique fingerprint.